Connor, Clark & Lunn Investment Management Ltd. Haemonetics Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Haemonetics Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 220,453 shares of HAE stock, worth $15.2 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
220,453
Previous 40,832
439.9%
Holding current value
$15.2 Million
Previous $3.38 Million
424.48%
% of portfolio
0.09%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding HAE
# of Institutions
334Shares Held
54MCall Options Held
689KPut Options Held
345K-
Black Rock Inc. New York, NY5.96MShares$411 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.17MShares$357 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.44MShares$307 Million0.08% of portfolio
-
Wellington Management Group LLP Boston, MA4.2MShares$290 Million0.06% of portfolio
-
Neuberger Berman Group LLC New York, NY4.03MShares$278 Million0.26% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.54B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...